Publications by authors named "Ravi Metlapally"

Claim this Profile
P
Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies.
Jeffrey S Heier, Eleonora M Lad, Frank G Holz, Philip J Rosenfeld, Robyn H Guymer, Ravi Metlapally

Immunotherapy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Jeffrey S Heier, Eleonora M Lad, Frank G Holz, Philip J Rosenfeld, Robyn H Guymer, Ravi Metlapally

Lancet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegcetacoplan treatment for geographic atrophy due to age-related macular degeneration: a plain language summary of the FILLY study.
David S Liao, Ravi Metlapally, Preeti Joshi

Immunotherapy· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Pegcetacoplan With Progression of Incomplete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration: A Post Hoc Analysis of the FILLY Randomized Clinical Trial.
Muneeswar Gupta Nittala, Ravi Metlapally, Michael Ip, Usha Chakravarthy, Frank G Holz

JAMA Ophthalmol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy.
Charles C Wykoff, Philip J Rosenfeld, Nadia K Waheed, Rishi P Singh, Nick Ronca, Ravi Metlapally

Ophthalmology· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor Pegcetacoplan.
Nathan C Steinle, Ian Pearce, Jordi Monés, Ravi Metlapally, Namrata Saroj

Am J Ophthalmol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scleral Mechanisms Underlying Ocular Growth and Myopia.
Ravi Metlapally, Christine F Wildsoet

Prog Mol Biol Transl Sci· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis